OTCMKTS:NSTM NovelStem International (NSTM) Stock Price, News & Analysis → Reclusive millionaire’s final warning about America (From Weiss Ratings) (Ad) Free NSTM Stock Alerts $0.07 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$0.07▼$0.0750-Day Range$0.06▼$0.0752-Week Range$0.06▼$0.28VolumeN/AAverage Volume373 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings Get NovelStem International alerts: Email Address Ad Behind the MarketsProtect Your Bank Account from ChinaChina is set to launch a gold-backed currency that could shake the financial world. This move will give them unprecedented power over global finance. And could divert trillions from U.S. Treasury bonds.Discover these 4 simple steps here >>> About NovelStem International Stock (OTCMKTS:NSTM)NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is based in Boca Raton, Florida.Read More NSTM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NSTM Stock News HeadlinesJuly 13, 2023 | finance.yahoo.comArbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and MerchandisingApril 24, 2023 | forbes.comGlencore InternationalMarch 31, 2023 | finance.yahoo.comNovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports 2022 Results on Form 10-KDecember 14, 2022 | finance.yahoo.comNovelStem's Affiliate NewStem Announced New Collaboration to Validate Its Software Diagnostic Device for Two Oncology Indications and Two TherapiesOctober 20, 2022 | finance.yahoo.comNovelStem International Corp. (NSTM)October 13, 2022 | finance.yahoo.comNovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding, Provides Financial UpdateAugust 27, 2022 | reuters.comNovelstem International CorpApril 15, 2022 | yahoo.comBreast cancer survivor says her sports bra saved her lifeApril 14, 2022 | yahoo.com9 Things That Millennials Who Grew Up In Puerto Rico Will RememberApril 14, 2022 | yahoo.comLatinx People Are Sharing Are Sharing "Untraditional" Beauty Tips From Their Abuelas And Moms, And I'm Taking NotesApril 11, 2022 | finance.yahoo.comNovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary Life-Saving, Treatment-Changing Diagnostic Device by 30%-Owned NewStem, LtdFebruary 17, 2022 | yahoo.comCampaigns With Heart Honored As 2022 Halo Award FinalistsFebruary 17, 2022 | yahoo.comMedi-Weightloss Celebrates Growth and Prepares for Expansion in 2022February 15, 2022 | finance.yahoo.comNovelStem Reviews Efforts to Maximize Value from Legacy Entertainment AssetJanuary 23, 2022 | nasdaq.comNovelStem International Corp (NSTM)See More Headlines Receive NSTM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovelStem International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today6/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Retail stores, not elsewhere classified Sub-IndustryN/A Current SymbolOTCMKTS:NSTM CUSIPN/A CIK912544 Webwww.novelstem.com Phone410-654-3315Fax561-998-2974Employees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,190,000.00 Net MarginsN/A Pretax Margin-26,419.30% Return on Equity-2,613.09% Return on Assets-192.35% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual Sales$10,000.00 Price / Sales351.13 Cash FlowN/A Price / Cash FlowN/A Book Value$0.04 per share Price / Book1.87Miscellaneous Outstanding Shares46,880,000Free FloatN/AMarket Cap$3.51 million OptionableNot Optionable Beta0.35 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Jan H. Loeb (Age 65)Executive Chairman & President Mr. Mitchell Rubenstein (Age 70)Co-Founder & Independent Director Ms. Christine Jenkins (Age 60)VP, CFO & Secretary Comp: $54kMr. David CollinsInvestor Relations Firm, Catalyst IRKey CompetitorsAble EnergyOTCMKTS:ABLESpendSmart NetworksOTCMKTS:SSPCYoshitsuNASDAQ:TKLFJD.comNASDAQ:JDUlta BeautyNASDAQ:ULTAView All Competitors NSTM Stock Analysis - Frequently Asked Questions How have NSTM shares performed in 2024? NovelStem International's stock was trading at $0.0629 at the start of the year. Since then, NSTM shares have increased by 19.1% and is now trading at $0.0749. View the best growth stocks for 2024 here. How were NovelStem International's earnings last quarter? NovelStem International Corp. (OTCMKTS:NSTM) released its quarterly earnings data on Wednesday, May, 15th. The company reported ($0.01) earnings per share for the quarter. How do I buy shares of NovelStem International? Shares of NSTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NSTM) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | SponsoredBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovelStem International Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovelStem International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.